CellMaxLife, University Gastroenterology & more: 3 GI company key notes

Here are three updates on gastroenterology companies to note:

CellMax Life's blood-based cancer detecting test can detect adenomas with close to 90 percent accuracy and cancer at 95 percent accuracy.

Eric Berthiaume, MD, was named Providence, R.I.-based University Gastroenterology's president.

Exelixis' cabozantinib was approved for use in patients with liver cancer. The drug was already approved for thyroid and renal cancer patients.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Learning Opportunities

Featured Webinars

Featured Whitepapers

Featured Podcast